Risk impact of edoxaban in the management of stroke and venous thromboembolism

The new generation of target-specific oral anticoagulants is being prescribed for increasing numbers of patients at risk of stroke or venous thromboembolism (VTE). These drugs offer valuable benefits due to fast onset anticoagulation, a fixed anticoagulation effect (allowing administration of specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurst, Katherine V, O’Callaghan, John Matthew, Handa, Ashok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986674/
https://www.ncbi.nlm.nih.gov/pubmed/27563246
http://dx.doi.org/10.2147/VHRM.S94679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986674/
https://www.ncbi.nlm.nih.gov/pubmed/27563246
http://dx.doi.org/10.2147/VHRM.S94679

Ejemplares similares